Zuellig Pharma invests in Singapore-based start-up Klinify
Zuellig Pharma, a leading provider of pharmaceutical logistics services in Asia Pacific, has invested in a Singapore-based healthtech startup named Klinify, a cloud-based clinic management solution that helps doctors go digital, without interrupting their work processes.
Maarten Kelder, Zuellig Pharma head of Strategy & Solutions, said the technology is a game-changer for the healthcare industry.
Klinify helps make the digitization of medical information much more efficient by helping doctors migrate to electronic records using tablets, Kelder said.“This gives doctors more time to spend with patients as it reduces their administrative burden and ensures that they have patients’ medical records easily available whenever they are needed,” he added.
He said the new partnership will focus on making Klinify a ‘one-stop-shop’ for doctors.
“We see Klinify as a platform to bring clinic management into the digital age. We will do this by making existing Zuellig Pharma services such as product ordering and inventory management available through the application. This will make it easy for doctors to automate these processes, reducing the complexity of clinic management.”
Klinify Founder and CEO Krishanthan Surendran said the partnership with Zuellig Pharma will accelerate the adoption of Klinify across the region.
“Zuellig Pharma has been operating in Asia for almost a century. It has relationships with tens of thousands of clinics across Asia, providing us with reach and access to new customers and markets.
The ability to integrate Zuellig Pharma’s existing logistics services will mean doctors get significantly more value out of Klinify as it will create a single portal for many of their clinic management needs.”
Zuellig Pharma Corporate Venture & Partnerships manager Benjamin Belot said Klinify will help doctors extend care beyond clinic walls.
“As the region’s healthcare needs continue to grow and evolve, we need to find ways to support patients in new ways. By integrating Zuellig Pharma’s services and solutions, Klinify has the potential to help doctors manage their patients’ conditions remotely.”
Zuellig Pharma’s investment in Klinify follows the launch of the company’s new Singapore-based innovation center.
Zuellig Pharma will invest more than US$50 million in this centre over the next five years to develop new solutions and technology that will better serve the needs of the healthcare community.
“Klinify is part of this commitment,” said Kelder. “We want to work with entrepreneurs like Krishanthan to enable the growth and development of exciting new solutions that have the potential to make healthcare more accessible in Asia.”
